IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Johnson Matthey to Form API Joint Venture for Chinese Market

6:19 AM MDT | April 27, 2010 | Deepti Ramesh

Aoxing Pharmaceutical (Shijiazhuang, China) says it has entered into an agreement with Johnson Matthey to establish a joint venture through affiliated companies, which will focus on the research, development, manufacturing and marketing of active pharmaceutical ingredients (API) for narcotics and neurological drugs for the Chinese market. Macfarlan Smith (Edinburgh, U.K.), a wholly owned subsidiary of Johnson Matthey, will contribute technology expertise and capital to the jv, and Hebei Aoxing Pharmaceutical, the operating subsidiary of Aoxing, will contribute...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa